WO2001017586A1 - Vascular introducer sheath and hemostasis valve for use therewith - Google Patents
Vascular introducer sheath and hemostasis valve for use therewith Download PDFInfo
- Publication number
- WO2001017586A1 WO2001017586A1 PCT/US2000/020581 US0020581W WO0117586A1 WO 2001017586 A1 WO2001017586 A1 WO 2001017586A1 US 0020581 W US0020581 W US 0020581W WO 0117586 A1 WO0117586 A1 WO 0117586A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gasket
- hub
- introducer sheath
- cap
- hemostasis valve
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M39/0606—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof without means for adjusting the seal opening or pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/062—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof used with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
- A61M2039/064—Slit-valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/04—Access sites having pierceable self-sealing members
- A61M39/045—Access sites having pierceable self-sealing members pre-slit to be pierced by blunt instrument
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T137/00—Fluid handling
- Y10T137/7722—Line condition change responsive valves
- Y10T137/7837—Direct response valves [i.e., check valve type]
- Y10T137/7879—Resilient material valve
- Y10T137/788—Having expansible port
Definitions
- the present invention generaiiy relates to introducer sheaths for use in procedures requiring vascular access. More specifically, the present invention relates to hemostasis valves for use in such introducer sheaths.
- Vascular introducer sheaths are well known components of vascular access systems which are used in a wide variety of diagnostic and therapeutic vascular procedures, such as angiography, angioplasty, thermolysis and embolization procedures.
- Vascular access systems typically include an introducer sheath for use in combination with a guide wire and a dilator.
- the introducer sheaths usually include a hemostatic or hemostasis valve which inhibits blood loss as guide wires, catheters and the like are introduced and manipulated in the vasculature via the sheath.
- An example of a known hemostasis valve is disclosed in U.S. Patent No.
- Davila '655 discloses a hemostasis valve including an inner housing, an end cap and a valve partition disposed between the inner housing and the end cap.
- the end cap includes a compression ring having a diameter which is less than the diameter of the valve partition but greater than the diameter of the aperture in the end cap and the bore in the inner housing.
- the compression ring causes the valve partition to bow outwardly. Purportedly, the bowing enhances the sealing of the slit in the valve partition.
- the compression ring creates stress concentration points on the valve partition that may compromise the integrity of the valve partition. Furthermore, an excessive amount of compression must be applied by the compression ring against the valve partition to impart the bowing effect.
- Paul '099 discloses a hemostatic valve including a gasket seal contained in a valve body and compressed therein by a cap connected to the valve body.
- the valve body includes a valve seat, which in turn includes a flange and a series of annular recessed steps.
- the flange serves to impart a concave shape to the gasket seal.
- the series of annular steps serve to prevent the gasket seal from being displaced.
- the hemostasis valve disclosed in Davila '655 suffers from the creation of stress concentration points imparted by the flange onto the valve gasket.
- the annular steps recessed in the valve body may also create stress concentration points on the gasket seal. These stress concentration points may compromise the integrity of the gasket seal and also require an excessive amount of compression to impart the desired curved shape of the gasket seal.
- the present invention overcomes these disadvantages by providing, in an exemplary embodiment, a vascular introducer sheath for use with a vascular access system.
- the vascular introducer sheath includes a tubular shaft and a hemostasis valve assembly connected to the proximal end of the tubular shaft.
- the hemostasis valve assembly includes a hub, a cap and a gasket disposed therebetween.
- the gasket may be normally-flat and may have at least one normally-closed slit extending therethrough.
- Both the hub and the cap include continuous contact surfaces facing the top and bottom surfaces of the gasket.
- the continuous contact surfaces may be flat or gently curved, and may be smooth or include a means to grip the gasket. At least one of the contact surfaces forms a non-orthogonal angle with the longitudinal axis of the assembly to cause the gasket to become curved in response to compression between the hub and the cap.
- the continuous contact surfaces uniformly distribute forces onto the perimeter of the gasket to avoid stress concentration points that may compromise gasket integrity.
- the continuous contact surfaces increase the contact surface area and thereby reduce the amount of pressure necessary to impart the desired curved shape of the gasket.
- FIG. 1 is a plan view of a vascular access system of the present invention including an introducer sheath and a dilator;
- Fig. 2 is a cross-sectional side view of a hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in Fig. 1 ;
- Fig. 3 is a cross-sectional side view of an alternative hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in Fig. l;
- Fig. 4 is a cross-sectional side view of another alternative hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in Fig. l;
- Fig. 5 is an isometric perspective view of a gasket for use with any of the hemostasis valve assemblies of Figs. 2-4; and
- Figs. 6A and 6B are a cross-sectional views of the gasket illustrated in Fig. 5, shown in the normal (relaxed) state and the curved (compressed) state, respectively. Detailed Description of the Invention
- FIG. 1 illustrates a plan view of a vascular access system 10 in accordance with the present invention.
- Vascular access system 10 includes two primary components, namely an introducer sheath 12 and a dilator 14.
- Introducer sheath 12 includes an elongate shaft 16 and a hemostasis valve assembly 18.
- the hemostasis valve assembly 18 is connected to the proximal end of the shaft 16 utilizing conventional techniques.
- Hemostasis valve assembly 18 includes a hub, a cap and a gasket disposed therebetween as will be described in greater detail with reference to Figures 2-4.
- the hub of the hemostasis assembly 18 may include a side port 19 for connection to a flush or injection tube subassembly 20.
- the shaft 16 of the introducer 12 may have a size (outside ' . ⁇ iameter or profile) ranging from 4F to 9F, and a length ranging from 10 cm to 25 cm.
- the distal tip of the elongate shaft 16 is preferably tapered to facilitate smooth insertion into the vascular system and smooth transition to the dilator 14.
- FIG. 2 illustrates a cross-sectional side view of the hemostasis valve assembly 18 for use with the introducer sheath 12 illustrated in Figure 1.
- the hemostasis valve assembly 18 includes a hub 22, a cap 24 and a gasket 26 disposed therebetween.
- the side port 19 of the hub 22 is not illustrated.
- the hub 22 and the end cap 24 include a means for compressive connection therebetween, such as a snap-fit connection or a threaded connection, both of which are well-known in the art.
- the hub 22 includes an inner lumen 28 extending therethrough, and the end cap 24 includes an aperture 30 extending therethrough.
- the inner lumen 28 of the hub 22 is in fluid communication with the aperture 30 of the end cap 24 absent the gasket 26, which includes one or more slits (not shown) discussed in more detail with reference to Figures 5, 6 A and 6B.
- the hub 22 and the end cap 24 may have conventional dimensions and may be formed of conventional materials using known manufacturing techniques.
- Hub 22 includes a continuous surface 32 which is in intimate contact with the bottom surface 34 of the gasket 26.
- the end cap 24 includes a continuous surface 36 in intimate contact with the top surface 38 of the gasket 26.
- the continuous contact surfaces 32, 36 may be flat or gently curved and may be smooth or include a means to grip the gasket as described with reference to Figs. 3 and 4.
- Both the surface 32 of the hub 22 and the surface 36 of the end cap 24 define a line 41 that is tangent to the surface. If a curved surface is used, the tangent line 41 may be taken at the cross-sectional mid-point of the curved surface. Either the tangent line 41 of surface 32 or the tangent lines 41 of both surfaces 32, 36 may be formed at an angle 40 with the longitudinal axis 42 of the assembly 18. The angle 40 is non-orthogonal (i.e. acute or obtuse; such that the gasket 26 becomes curved in response to compression between the hub 22 and the end cap 24.
- the continuous surfaces 32, 36 which may be flat or gently curved, uniformly distribute forces onto the bottom and top surfaces 34, 38 to avoid stress concentration points that may otherwise compromise the integrity of the gasket 26.
- the continuous contact surfaces 32, 36 increase the contact surface area and thereby reduce the amount of pressure between the hub 22 and the end cap 24 necessary to impart the desired curved shape of the gasket 26.
- the continuous surfaces 32, 36 form an acute angle 40 with the longitudinal axis 42 such that the top surface 38 of the gasket 26 assumes a convex shape.
- the continuous surfaces 32, 36 may form an obtuse angle 40 with the longitudinal axis 42 such that the top surface 38 assumes a concave shape.
- the surface 32 of the hub 22 is formed at an angle 40 with the longitudinal axis 42 in order to impart a curve on the gasket 26.
- both the surface 32 of the hub and the surface 36 of the end cap 24 may be formed at an angle 40 to cause the gasket 26 to assume a curved shape. If both surfaces 32, 36 are formed at an angle 40, the angles are preferably the same but may be different.
- FIG. 3 illustrates a cross-sectional side view of an alternative hemostasis valve assembly 48 for use with the introducer sheath 12 illustrated in Figure 1.
- hemostasis valve assembly 48 is the same in form and function as hemostasis valve 18.
- the end cap 24 includes a non-orthogonal continuous surface 36 as described previously, and a flat surface 37 that is orthogonal to the axis 42. By providing an orthogonal flat surface 37, the gasket 26 is less likely to be displaced from the recess formed between the hub 22 and the end cap 24.
- FIG. 4 illustrates a cross-sectional side view of another alternative hemostasis valve assembly 58 for use with the introducer sheath illustrated in Figure 1. Except as specifically described herein, hemostasis valve 58 is the same in form and function as hemostasis valve assembly 18. For purposes of simplicity and clarity, the gasket 26 is not illustrated in Figure 4. It should be understood, however, that the gasket 26 is disposed between the hub 22 and the end cap 24 as described previously.
- the continuous surfaces 32, 36 of the hub 22 and the end cap 24, respectively, include an annular protrusion 44 to grip the gasket 26.
- Annular protrusion 44 preferably has a relatively low profile of less than approximately 0.010" to minimize or avoid creating stress concentration points on the gasket 26. It is believed that the annular protrusions 44 do not contribute to curving the gasket 26, but merely retain the gasket between the hub 22 and the cap 24.
- protrusions 44 and other suitable means for gripping the gasket 26 preferably do not significantly compromise the flatness or gentle curvature of the contact surfaces 32, 36 engaging the gasket 26.
- protrusions and other means to grip the gasket 26 merely increase resistance to displacement of the gasket 26 relative to the hub 22 and the end cap 24, but do not result in stress concentration or focal points that may otherwise compromise the integrity of the gasket 26.
- Gasket 26 includes a flat top surface 38 and a flat bottom surface 34 as described previously. Gasket 26 is normally flat such that the gasket 26 assumes a flat, disk shape when not in compression.
- the gasket 26 may be formed of a variety of elastimeric materials such as PDMS, latex or other suitable material.
- the gasket 26 has a durometer in the range of 15A-50A.
- the gasket 26 thickness may range from approximately 0.045 to 0.075 inches and may have an outside diameter ranging from 0.050 to 0.150 inches to snugly fit in the recess of the cap 24.
- the gasket 26 may be punched out of a sheet of elastimeric material or molded using conventional techniques.
- a slit 46 may be punched through the gasket 26 using a three-edged cutter or other suitable geometry, depending on the desired number and shape of the slits.
- FIGS. 6A and 6B illustrate cross-sectional views of the gasket 26 shown in the normal (relaxed) state 26A and the curved (compressed) state 26B, respectively.
- the normally flat gasket 26A illustrated in Figure 6A includes a slit 46 that is normally closed. Specifically, the slit 46 is normally closed at the top surface 38 and the bottom surface 34 of the gasket 26 such that a fluid tight seal is created along the entire length of the slit 46.
- the gasket 26B assumes a curved shape, depending on the degree of compression and the angle 40 of the contact surfaces 32, 36.
- the top surface 38 is shown to have a convex shape and the bottom surface 34 is shown to have a concave shape.
- the surface that assumes the convex shape creates an opening 52 while an enhanced fluid tight seal 54 is created along the concave surface.
- the opening 52 on the convex surface allows for easy insertion of a guide wire, catheter or the like, particularly when incorporated onto the top surface 38 of the gasket 26.
- the enhanced fluid tight seal 54 on the concave surface inhibits the egress of blood through the gasket 26.
- the size of the opening 52 and the amount of compression at the seal 54 depends in part on the degree of curvature of the gasket 26.
- the curvature of the gasket 26 may be adjusted by changing the angle 40 or the amount of compression to impart the desired size of the opening 52 and the desired tightness of the seal 54.
- the amount of curvature may be adjusted to affect device performance in terms of hemostasis (i.e., seal) and resistance (i.e., drag) to movement of devices passing therethrough.
- the improved hemostasis valve assemblies provide continuous (e.g., flat or gently curved) contact surfaces between the gasket and the housing components (i.e., the hub and end cap).
- the continuous contact surfaces distribute forces uniformly onto the perimeter of the gasket to avoid stress concentration points that may otherwise compromise gasket integrity.
- the continuous contact surfaces increase the amount of contact area and thereby reduce the amount of pressure necessary to impart the desired curved shape of the gasket.
Abstract
This invention is a vascular introducer sheath (12) including a shaft (16), and a hemostasis valve assembly (18) connected to the proximal end thereof. The hemostasis valve assembly (18) includes a hub, a cap and a normally-flat gasket disposed therebetween. Both the hub (22), and the cap (24) include continuous curved contact surfaces facing the top (38), and bottom (34) surfaces of the gasket (26). The continuous contact surfaces (32, 36) may be flat or gently curved, and may be smooth or include a means to grip the gasket (26). At least one of the contact (26) surfaces is formed at an angle to cause the gasket to become convex or concave in response to compression between the hub (22), and the cap (24). The continuous contact surfaces (32, 36) uniformly distribute forces onto the perimeter of the gasket (26) to avoid stress concentration points that may compromise gasket integrity. In addition, the continuous contact surfaces (32, 36) reduce the amount of pressure necessary to impart the curved shape of the gasket (26).
Description
VASCULAR INTRODUCER SHEATH AND HEMOSTASIS VALVE FOR USE THEREWITH
Field of the Invention The present invention generaiiy relates to introducer sheaths for use in procedures requiring vascular access. More specifically, the present invention relates to hemostasis valves for use in such introducer sheaths.
Background of the Invention
Vascular introducer sheaths are well known components of vascular access systems which are used in a wide variety of diagnostic and therapeutic vascular procedures, such as angiography, angioplasty, thermolysis and embolization procedures. Vascular access systems typically include an introducer sheath for use in combination with a guide wire and a dilator. The introducer sheaths usually include a hemostatic or hemostasis valve which inhibits blood loss as guide wires, catheters and the like are introduced and manipulated in the vasculature via the sheath. An example of a known hemostasis valve is disclosed in U.S. Patent No.
5,520,655 to Davila et al. Davila '655 discloses a hemostasis valve including an inner housing, an end cap and a valve partition disposed between the inner housing and the end cap. The end cap includes a compression ring having a diameter which is less than the diameter of the valve partition but greater than the diameter of the aperture in the end cap and the bore in the inner housing. With this arrangement, the compression ring causes the valve partition to bow outwardly. Purportedly, the bowing enhances the sealing of the slit in the valve partition. However, the compression ring creates stress concentration points on the valve partition that may compromise the integrity of the valve partition. Furthermore, an excessive amount of compression must be applied by the compression ring against the valve partition to impart the bowing effect.
A similar hemostasis valve is disclosed in International Patent Publication No. WO 99/06099 to Paul. Paul '099 discloses a hemostatic valve including a gasket seal contained in a valve body and compressed therein by a cap connected to the valve body. The valve body includes a valve seat, which in turn includes a flange and a series of annular recessed steps. The flange serves to impart a concave shape to the gasket seal. The series of annular steps serve to prevent the gasket seal from being displaced. As with the hemostasis valve disclosed in Davila '655, the hemostasis valve disclosed in Paul '099 suffers from the creation of stress concentration points
imparted by the flange onto the valve gasket. The annular steps recessed in the valve body, depending on the size, may also create stress concentration points on the gasket seal. These stress concentration points may compromise the integrity of the gasket seal and also require an excessive amount of compression to impart the desired curved shape of the gasket seal.
Summary of the Invention The present invention overcomes these disadvantages by providing, in an exemplary embodiment, a vascular introducer sheath for use with a vascular access system. The vascular introducer sheath includes a tubular shaft and a hemostasis valve assembly connected to the proximal end of the tubular shaft. The hemostasis valve assembly includes a hub, a cap and a gasket disposed therebetween. The gasket may be normally-flat and may have at least one normally-closed slit extending therethrough.
Both the hub and the cap include continuous contact surfaces facing the top and bottom surfaces of the gasket. The continuous contact surfaces may be flat or gently curved, and may be smooth or include a means to grip the gasket. At least one of the contact surfaces forms a non-orthogonal angle with the longitudinal axis of the assembly to cause the gasket to become curved in response to compression between the hub and the cap. The continuous contact surfaces uniformly distribute forces onto the perimeter of the gasket to avoid stress concentration points that may compromise gasket integrity. In addition, the continuous contact surfaces increase the contact surface area and thereby reduce the amount of pressure necessary to impart the desired curved shape of the gasket.
Brief Description of the Drawings Fig. 1 is a plan view of a vascular access system of the present invention including an introducer sheath and a dilator;
Fig. 2 is a cross-sectional side view of a hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in Fig. 1 ;
Fig. 3 is a cross-sectional side view of an alternative hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in Fig. l;
Fig. 4 is a cross-sectional side view of another alternative hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in Fig. l;
Fig. 5 is an isometric perspective view of a gasket for use with any of the hemostasis valve assemblies of Figs. 2-4; and
Figs. 6A and 6B are a cross-sectional views of the gasket illustrated in Fig. 5, shown in the normal (relaxed) state and the curved (compressed) state, respectively. Detailed Description of the Invention
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention. Refer now to Figure 1 which illustrates a plan view of a vascular access system 10 in accordance with the present invention. Vascular access system 10 includes two primary components, namely an introducer sheath 12 and a dilator 14. Introducer sheath 12 includes an elongate shaft 16 and a hemostasis valve assembly 18. The hemostasis valve assembly 18 is connected to the proximal end of the shaft 16 utilizing conventional techniques. Hemostasis valve assembly 18 includes a hub, a cap and a gasket disposed therebetween as will be described in greater detail with reference to Figures 2-4. The hub of the hemostasis assembly 18 may include a side port 19 for connection to a flush or injection tube subassembly 20. The shaft 16 of the introducer 12 may have a size (outside '.ϊiameter or profile) ranging from 4F to 9F, and a length ranging from 10 cm to 25 cm. The distal tip of the elongate shaft 16 is preferably tapered to facilitate smooth insertion into the vascular system and smooth transition to the dilator 14.
Refer now to Figure 2 which illustrates a cross-sectional side view of the hemostasis valve assembly 18 for use with the introducer sheath 12 illustrated in Figure 1. As mentioned previously, the hemostasis valve assembly 18 includes a hub 22, a cap 24 and a gasket 26 disposed therebetween. For purposes of simplicity and clarity, the side port 19 of the hub 22 is not illustrated. Similarly, although not illustrated for purposes of simplicity and clarity, the hub 22 and the end cap 24 include a means for compressive connection therebetween, such as a snap-fit connection or a threaded connection, both of which are well-known in the art.
The hub 22 includes an inner lumen 28 extending therethrough, and the end cap 24 includes an aperture 30 extending therethrough. The inner lumen 28 of the hub 22 is in fluid communication with the aperture 30 of the end cap 24 absent the gasket 26, which includes one or more slits (not shown) discussed in more detail with
reference to Figures 5, 6 A and 6B. The hub 22 and the end cap 24 may have conventional dimensions and may be formed of conventional materials using known manufacturing techniques.
Hub 22 includes a continuous surface 32 which is in intimate contact with the bottom surface 34 of the gasket 26. Similarly, the end cap 24 includes a continuous surface 36 in intimate contact with the top surface 38 of the gasket 26. The continuous contact surfaces 32, 36 may be flat or gently curved and may be smooth or include a means to grip the gasket as described with reference to Figs. 3 and 4.
Both the surface 32 of the hub 22 and the surface 36 of the end cap 24 define a line 41 that is tangent to the surface. If a curved surface is used, the tangent line 41 may be taken at the cross-sectional mid-point of the curved surface. Either the tangent line 41 of surface 32 or the tangent lines 41 of both surfaces 32, 36 may be formed at an angle 40 with the longitudinal axis 42 of the assembly 18. The angle 40 is non-orthogonal (i.e. acute or obtuse; such that the gasket 26 becomes curved in response to compression between the hub 22 and the end cap 24.
The continuous surfaces 32, 36, which may be flat or gently curved, uniformly distribute forces onto the bottom and top surfaces 34, 38 to avoid stress concentration points that may otherwise compromise the integrity of the gasket 26. In addition, the continuous contact surfaces 32, 36 increase the contact surface area and thereby reduce the amount of pressure between the hub 22 and the end cap 24 necessary to impart the desired curved shape of the gasket 26.
As illustrated, the continuous surfaces 32, 36 form an acute angle 40 with the longitudinal axis 42 such that the top surface 38 of the gasket 26 assumes a convex shape. Alternatively, the continuous surfaces 32, 36 may form an obtuse angle 40 with the longitudinal axis 42 such that the top surface 38 assumes a concave shape. As mentioned previously, it is only necessary that the surface 32 of the hub 22 is formed at an angle 40 with the longitudinal axis 42 in order to impart a curve on the gasket 26. However, both the surface 32 of the hub and the surface 36 of the end cap 24 may be formed at an angle 40 to cause the gasket 26 to assume a curved shape. If both surfaces 32, 36 are formed at an angle 40, the angles are preferably the same but may be different.
Refer now to Figure 3 which illustrates a cross-sectional side view of an alternative hemostasis valve assembly 48 for use with the introducer sheath 12 illustrated in Figure 1. Except as specifically described herein, hemostasis valve
assembly 48 is the same in form and function as hemostasis valve 18. In this embodiment, the end cap 24 includes a non-orthogonal continuous surface 36 as described previously, and a flat surface 37 that is orthogonal to the axis 42. By providing an orthogonal flat surface 37, the gasket 26 is less likely to be displaced from the recess formed between the hub 22 and the end cap 24. Accordingly, the combination of an orthogonal flat surface 37 and a non-orthogonal continuous surface 36 retains the gasket 26 between the hub 22 and the end cap 24 while guide wires, catheters and the like are advanced or retracted through the hemostasis valve assembly 48. Refer now to Figure 4 which illustrates a cross-sectional side view of another alternative hemostasis valve assembly 58 for use with the introducer sheath illustrated in Figure 1. Except as specifically described herein, hemostasis valve 58 is the same in form and function as hemostasis valve assembly 18. For purposes of simplicity and clarity, the gasket 26 is not illustrated in Figure 4. It should be understood, however, that the gasket 26 is disposed between the hub 22 and the end cap 24 as described previously.
In this particular embodiment, the continuous surfaces 32, 36 of the hub 22 and the end cap 24, respectively, include an annular protrusion 44 to grip the gasket 26. Annular protrusion 44 preferably has a relatively low profile of less than approximately 0.010" to minimize or avoid creating stress concentration points on the gasket 26. It is believed that the annular protrusions 44 do not contribute to curving the gasket 26, but merely retain the gasket between the hub 22 and the cap 24.
Those skilled in the art will recognize that other means may be employed to grip the gasket 26. For example, a series of small knobs or ridges may be utilized. Alternatively, the contact surfaces 32, 36 may be provided with a coating having a high coefficient of friction or other roughened surface treatment. However, it is to be understood that protrusions 44 and other suitable means for gripping the gasket 26 preferably do not significantly compromise the flatness or gentle curvature of the contact surfaces 32, 36 engaging the gasket 26. These protrusions and other means to grip the gasket 26 merely increase resistance to displacement of the gasket 26 relative to the hub 22 and the end cap 24, but do not result in stress concentration or focal points that may otherwise compromise the integrity of the gasket 26.
Refer now to Figure 5 which illustrates an isometric perspective view of the gasket 26 for use with any of the hemostasis assemblies 18, 48, 58 illustrated in
Figures 2-4. Gasket 26 includes a flat top surface 38 and a flat bottom surface 34 as described previously. Gasket 26 is normally flat such that the gasket 26 assumes a flat, disk shape when not in compression. The gasket 26 may be formed of a variety of elastimeric materials such as PDMS, latex or other suitable material. Preferably, the gasket 26 has a durometer in the range of 15A-50A. The gasket 26 thickness may range from approximately 0.045 to 0.075 inches and may have an outside diameter ranging from 0.050 to 0.150 inches to snugly fit in the recess of the cap 24. The gasket 26 may be punched out of a sheet of elastimeric material or molded using conventional techniques. A slit 46 may be punched through the gasket 26 using a three-edged cutter or other suitable geometry, depending on the desired number and shape of the slits. Those skilled in the art will recognize that the dimensions, materials and methods of manufacture may be readily modified without departing from the scope or spirit of the invention.
Refer now to Figures 6A and 6B which illustrate cross-sectional views of the gasket 26 shown in the normal (relaxed) state 26A and the curved (compressed) state 26B, respectively. The normally flat gasket 26A illustrated in Figure 6A includes a slit 46 that is normally closed. Specifically, the slit 46 is normally closed at the top surface 38 and the bottom surface 34 of the gasket 26 such that a fluid tight seal is created along the entire length of the slit 46. Upon compression, the gasket 26B assumes a curved shape, depending on the degree of compression and the angle 40 of the contact surfaces 32, 36. For purposes of illustration only, the top surface 38 is shown to have a convex shape and the bottom surface 34 is shown to have a concave shape. The surface that assumes the convex shape creates an opening 52 while an enhanced fluid tight seal 54 is created along the concave surface. The opening 52 on the convex surface allows for easy insertion of a guide wire, catheter or the like, particularly when incorporated onto the top surface 38 of the gasket 26. The enhanced fluid tight seal 54 on the concave surface inhibits the egress of blood through the gasket 26.
The size of the opening 52 and the amount of compression at the seal 54 depends in part on the degree of curvature of the gasket 26. The curvature of the gasket 26 may be adjusted by changing the angle 40 or the amount of compression to impart the desired size of the opening 52 and the desired tightness of the seal 54. Thus, the amount of curvature may be adjusted to affect device performance in terms
of hemostasis (i.e., seal) and resistance (i.e., drag) to movement of devices passing therethrough.
From the foregoing, those skilled in the art will recognize that an improved vascular introducer sheath, and in particular an improved hemostasis valve assembly has been described. The improved hemostasis valve assemblies provide continuous (e.g., flat or gently curved) contact surfaces between the gasket and the housing components (i.e., the hub and end cap). The continuous contact surfaces distribute forces uniformly onto the perimeter of the gasket to avoid stress concentration points that may otherwise compromise gasket integrity. In addition, the continuous contact surfaces increase the amount of contact area and thereby reduce the amount of pressure necessary to impart the desired curved shape of the gasket.
Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.
- 1 ■
Claims
1. A vascular introducer sheath for use with a vascular access system, the vascular introducer sheath comprising: a tubular shaft having a proximal end and a distal end; and a hemostasis valve assembly connected to the proximal end of the tubular shaft, the hemostasis valve assembly including a hub having a longitudinal axis and a continuous contact surface, a cap having a continuous contact surface, and a gasket disposed therebetween, wherein at least one of the contact surfaces forms a non- orthogonal angle with longitudinal axis to cause the gasket to become curved in response to compression between the hub and the cap.
2. A vascular introducer sheath as in claim 1, wherein the continuous contact surfaces are flat.
3. A vascular introducer sheath as in claim 1, wherein the continuous contact surfaces are gently curved.
4. A vascular introducer sheath as in claim 1, wherein the gasket is normally-flat.
5. A vascular introducer sheath as in claim 4, wherein the gasket has at least one slit extending therethrough, the slit being normally-closed when the gasket is flat.
6. A vascular introducer sheath as in claim 1, wherein both contact surfaces form a non-orthogonal angle with longitudinal axis to cause the gasket to become curved in response to compression between the hub and the cap.
7. A vascular introducer sheath as in claim 6, wherein the angle is acute.
8. A vascular introducer sheath as in claim 7, wherein a top surface of the gasket is convex.
9. A vascular introducer sheath as in claim 6, wherein the angle is obtuse.
10. A vascular introducer sheath as in claim 9, wherein a top surface of the gasket is concave.
11. A vascular introducer sheath as in claim 1 , wherein at least one of the contact surfaces includes a means to retain the gasket between the hub and cap.
12. A vascular introducer sheath as in claim 11, wherein the retaining means comprises an orthogonal flat surface.
13. A hemostasis valve assembly for use with a vascular introducer sheath, the hemostasis valve assembly comprising: a hub having a continuous contact surface and a longitudinal axis; a cap co-axially disposed about the hub, the cap having a continuous contact surface; and a gasket disposed between the hub and cap, the gasket having a top surface and a bottom surface, the top surface disposed adjacent the contact surface of the hub and the bottom surface disposed adjacent the contact surface of the cap, wherein the contact surface of the hub forms a non-orthogonal angle with longitudinal axis to cause the gasket to become curved in response to compression between the hub and the cap.
14. A hemostasis valve assembly as in claim 13, wherein the continuous contact surfaces are flat.
15. A hemostasis valve assembly as in claim 13, wherein the continuous contact surfaces are gently curved.
16. A hemostasis valve assembly as in claim 13, wherein the gasket is normally-flat.
17. A hemostasis valve assembly as in claim 16, wherein the gasket has at least one slit extending from the top surface to the bottom surface, the slit being normally-closed at both the top and bottom surfaces when the gasket is flat.
18. A hemostasis valve assembly as in claim 13, wherein the contact surface of the hub forms an acute angle with longitudinal axis to cause the top surface of the gasket to become convex in response to compression between the hub and the cap.
19. A hemostasis valve assembly as in claim 13, wherein the contact surface of the hub forms an obtuse angle with longitudinal axis to cause the top surface of the gasket to become concave in response to compression between the hub and the cap.
20. A hemostasis valve assembly as in claim 13, wherein both contact surfaces form a non-orthogonal angle with longitudinal axis to cause the gasket to become curved in response to compression between the hub and the cap.
21. A vascular introducer sheath as in claim 13, wherein at least one of the contact surfaces includes a means to retain the gasket between the hub and cap.
22. A vascular introducer sheath as in claim 20, wherein the retaining means comprises an orthogonal flat surface.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2000616785 DE60016785T2 (en) | 1999-09-10 | 2000-07-28 | VASCULAR INTAKE SLEEVE AND HEMOSTATIC VALVE THEREFORE TO BE USED |
EP20000950838 EP1225932B1 (en) | 1999-09-10 | 2000-07-28 | Vascular introducer sheath and hemostasis valve for use therewith |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/393,865 | 1999-09-10 | ||
US09/393,865 US6322541B2 (en) | 1999-09-10 | 1999-09-10 | Vascular introducer sheath and hemostasis valve for use therewith |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001017586A1 true WO2001017586A1 (en) | 2001-03-15 |
Family
ID=23556562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/020581 WO2001017586A1 (en) | 1999-09-10 | 2000-07-28 | Vascular introducer sheath and hemostasis valve for use therewith |
Country Status (4)
Country | Link |
---|---|
US (1) | US6322541B2 (en) |
EP (1) | EP1225932B1 (en) |
DE (1) | DE60016785T2 (en) |
WO (1) | WO2001017586A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003008035A1 (en) * | 2001-07-16 | 2003-01-30 | Boston Scientific Limited | Hemostasis gasket valve |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9517622D0 (en) | 1995-08-29 | 1995-11-01 | Univ Edinburgh | Regulation of intracellular glucocorticoid concentrations |
EP0976365A1 (en) * | 1998-07-27 | 2000-02-02 | Osteo Ag | Tibia nail for retrograde insertion |
US7314477B1 (en) | 1998-09-25 | 2008-01-01 | C.R. Bard Inc. | Removable embolus blood clot filter and filter delivery unit |
US7537564B2 (en) | 1998-12-01 | 2009-05-26 | Atropos Limited | Wound retractor device |
US7559893B2 (en) | 1998-12-01 | 2009-07-14 | Atropos Limited | Wound retractor device |
US20040097996A1 (en) | 1999-10-05 | 2004-05-20 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode |
ATE415867T1 (en) | 1999-10-14 | 2008-12-15 | Atropos Ltd | SURGICAL WOUND RETRACTOR |
US6712789B1 (en) | 2000-07-13 | 2004-03-30 | Medamicus, Inc. | Introducer having a movable valve assembly with removable side port |
EP1326524B1 (en) | 2000-10-19 | 2010-09-01 | Applied Medical Resources Corporation | Surgical access apparatus and method |
CA2457687C (en) | 2001-08-14 | 2013-01-15 | Applied Medical Resources Corporation | Access sealing apparatus and method |
US6958037B2 (en) | 2001-10-20 | 2005-10-25 | Applied Medical Resources Corporation | Wound retraction apparatus and method |
WO2003070313A1 (en) * | 2002-02-19 | 2003-08-28 | Medamicus, Inc. | Composite stasis valve |
US9204956B2 (en) | 2002-02-20 | 2015-12-08 | C. R. Bard, Inc. | IVC filter with translating hooks |
US20030163147A1 (en) * | 2002-02-22 | 2003-08-28 | Rabiner Robert A. | Apparatus and method for using a vascular introducer with an ultrasonic probe |
US7650887B2 (en) | 2002-06-05 | 2010-01-26 | Applied Medical Resources Corporation | Wound retractor |
US9271753B2 (en) | 2002-08-08 | 2016-03-01 | Atropos Limited | Surgical device |
US7422571B2 (en) | 2002-08-29 | 2008-09-09 | Medical Components, Inc. | Releasably locking dilator and sheath assembly |
DE60314464T2 (en) | 2002-09-19 | 2008-02-14 | Atropos Ltd., Bray | SURGICAL WOUND RETRACTOR |
US20050020884A1 (en) | 2003-02-25 | 2005-01-27 | Hart Charles C. | Surgical access system |
US7435236B2 (en) | 2003-06-27 | 2008-10-14 | Navilyst Medical, Inc. | Pressure actuated valve with improved biasing member |
WO2005013803A2 (en) | 2003-08-06 | 2005-02-17 | Applied Medical Resources Corporation | Surgical device with tack-free gel and method of manufacture |
US7163510B2 (en) | 2003-09-17 | 2007-01-16 | Applied Medical Resources Corporation | Surgical instrument access device |
US7794414B2 (en) | 2004-02-09 | 2010-09-14 | Emigrant Bank, N.A. | Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes |
US7594910B2 (en) | 2004-03-18 | 2009-09-29 | C. R. Bard, Inc. | Catheter connector |
US7594911B2 (en) | 2004-03-18 | 2009-09-29 | C. R. Bard, Inc. | Connector system for a proximally trimmable catheter |
US8083728B2 (en) | 2004-03-18 | 2011-12-27 | C. R. Bard, Inc. | Multifunction adaptor for an open-ended catheter |
US7854731B2 (en) | 2004-03-18 | 2010-12-21 | C. R. Bard, Inc. | Valved catheter |
US7377915B2 (en) | 2004-04-01 | 2008-05-27 | C. R. Bard, Inc. | Catheter connector system |
EP1740253B1 (en) | 2004-04-30 | 2008-08-13 | C.R.Bard, Inc. | Valved sheath introducer for venous cannulation |
US7704267B2 (en) | 2004-08-04 | 2010-04-27 | C. R. Bard, Inc. | Non-entangling vena cava filter |
JP2008515523A (en) | 2004-10-11 | 2008-05-15 | アトロポス・リミテッド | Instrument access device |
US7794473B2 (en) | 2004-11-12 | 2010-09-14 | C.R. Bard, Inc. | Filter delivery system |
US8932260B2 (en) | 2004-11-29 | 2015-01-13 | C. R. Bard, Inc. | Reduced-friction catheter introducer and method of manufacturing and using the same |
US8403890B2 (en) | 2004-11-29 | 2013-03-26 | C. R. Bard, Inc. | Reduced friction catheter introducer and method of manufacturing and using the same |
US8926564B2 (en) | 2004-11-29 | 2015-01-06 | C. R. Bard, Inc. | Catheter introducer including a valve and valve actuator |
US9597483B2 (en) | 2004-11-29 | 2017-03-21 | C. R. Bard, Inc. | Reduced-friction catheter introducer and method of manufacturing and using the same |
US8267954B2 (en) | 2005-02-04 | 2012-09-18 | C. R. Bard, Inc. | Vascular filter with sensing capability |
JP5102201B2 (en) | 2005-05-12 | 2012-12-19 | シー・アール・バード・インコーポレーテッド | Removable embolic clot filter |
US7875019B2 (en) | 2005-06-20 | 2011-01-25 | C. R. Bard, Inc. | Connection system for multi-lumen catheter |
JP2009501045A (en) | 2005-07-15 | 2009-01-15 | アトロポス・リミテッド | Wound retractor |
JP4851522B2 (en) | 2005-08-09 | 2012-01-11 | シー・アール・バード・インコーポレーテッド | Insertion type thrombus filter and delivery system |
EP1933730B1 (en) | 2005-10-14 | 2010-02-24 | Applied Medical Resources Corporation | Split hoop wound retractor with gel pad |
CA2940038C (en) | 2005-11-18 | 2018-08-28 | C.R. Bard, Inc. | Vena cava filter with filament |
EP1954343B1 (en) | 2005-12-02 | 2012-01-18 | C.R.Bard, Inc. | Pressure-activated proximal valves |
WO2007133366A2 (en) | 2006-05-02 | 2007-11-22 | C. R. Bard, Inc. | Vena cava filter formed from a sheet |
CA2655158A1 (en) | 2006-06-05 | 2007-12-13 | C.R. Bard Inc. | Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access |
JP4994775B2 (en) | 2006-10-12 | 2012-08-08 | 日本コヴィディエン株式会社 | Needle point protector |
JP5441890B2 (en) | 2007-05-11 | 2014-03-12 | アプライド メディカル リソーシーズ コーポレイション | Surgical retractor with gel pad |
JP5231534B2 (en) | 2007-05-11 | 2013-07-10 | アプライド メディカル リソーシーズ コーポレイション | Surgical retractor |
US8657740B2 (en) | 2007-06-05 | 2014-02-25 | Atropos Limited | Instrument access device |
WO2008149332A1 (en) | 2007-06-05 | 2008-12-11 | Atropos Limited | An instrument access device |
EP3456372A1 (en) * | 2007-06-22 | 2019-03-20 | Medical Components, Inc. | Tearaway sheath assembly with hemostasis valve |
WO2009038727A1 (en) * | 2007-09-18 | 2009-03-26 | Medical Components, Inc. | Tearaway sheath assembly with split hemostasis valve |
CN101903062A (en) | 2007-10-19 | 2010-12-01 | C·R·巴德股份有限公司 | Introducer including shaped distal region |
WO2009094476A1 (en) | 2008-01-22 | 2009-07-30 | Applied Medical Resources Corporation | Surgical instrument access device |
WO2009114456A1 (en) * | 2008-03-14 | 2009-09-17 | Medical Components, Inc. | Tearaway introducer sheath with hemostasis valve |
US8257321B2 (en) * | 2008-05-21 | 2012-09-04 | Navilyst Medical, Inc. | Pressure activated valve for high flow rate and pressure venous access applications |
EP3275386B1 (en) | 2008-10-13 | 2024-01-03 | Applied Medical Resources Corporation | Single port access system |
JP5606688B2 (en) * | 2009-02-05 | 2014-10-15 | 内外化成株式会社 | Medical cap and method for manufacturing the same |
US8375955B2 (en) | 2009-02-06 | 2013-02-19 | Atropos Limited | Surgical procedure |
JP5606684B2 (en) * | 2009-03-23 | 2014-10-15 | 内外化成株式会社 | Medical cap and method for manufacturing the same |
US8337484B2 (en) | 2009-06-26 | 2012-12-25 | C. R. Band, Inc. | Proximally trimmable catheter including pre-attached bifurcation and related methods |
US8007468B2 (en) | 2009-07-13 | 2011-08-30 | Navilyst Medical, Inc. | Method to secure an elastic component in a valve |
ES2717424T3 (en) | 2009-07-29 | 2019-06-21 | Bard Inc C R | Tubular filter |
JP5455205B2 (en) * | 2009-08-11 | 2014-03-26 | 内外化成株式会社 | Medical cap and method for manufacturing the same |
WO2011033495A1 (en) | 2009-09-17 | 2011-03-24 | Atropos Limited | An instrument access device |
US9289200B2 (en) | 2010-10-01 | 2016-03-22 | Applied Medical Resources Corporation | Natural orifice surgery system |
US9289115B2 (en) | 2010-10-01 | 2016-03-22 | Applied Medical Resources Corporation | Natural orifice surgery system |
US8486024B2 (en) | 2011-04-27 | 2013-07-16 | Covidien Lp | Safety IV catheter assemblies |
ES2822115T3 (en) | 2011-05-10 | 2021-04-29 | Applied Med Resources | Wound retractor device |
EP2730308B1 (en) * | 2011-07-04 | 2016-12-28 | Terumo Kabushiki Kaisha | Introducer sheath |
EP2760520A1 (en) | 2011-09-26 | 2014-08-06 | Covidien LP | Safety catheter |
WO2013048768A1 (en) | 2011-09-26 | 2013-04-04 | Covidien Lp | Safety iv catheter and needle assembly |
WO2013056223A1 (en) | 2011-10-14 | 2013-04-18 | Covidien Lp | Safety iv catheter assembly |
KR102300866B1 (en) | 2013-03-15 | 2021-09-13 | 어플라이드 메디컬 리소시스 코포레이션 | Mechanical gel surgical access device |
JP6417705B2 (en) * | 2014-05-13 | 2018-11-07 | ニプロ株式会社 | Hub with valve |
ES2703184T3 (en) | 2014-07-18 | 2019-03-07 | Applied Med Resources | Method for manufacturing gels that have permanent tack-free coatings |
EP4101405A1 (en) | 2014-08-15 | 2022-12-14 | Applied Medical Resources Corporation | Natural orifice surgery system |
CA2967015C (en) | 2014-11-07 | 2023-02-28 | C.R. Bard, Inc. | Connection system for tunneled catheters |
EP3223718A2 (en) | 2014-11-25 | 2017-10-04 | Applied Medical Resources Corporation | Circumferential wound retraction with support and guidance structures |
US10010344B2 (en) * | 2015-07-13 | 2018-07-03 | Dennis L Steffen | Self-dilating catheter introducer with obturator and method of use |
CN107708790B (en) * | 2015-08-17 | 2023-05-02 | 株式会社戈德曼 | Medical device cartridge, medical device, and method for manufacturing medical device cartridge |
ES2836282T3 (en) | 2015-09-15 | 2021-06-24 | Applied Med Resources | Surgical robotic access system |
EP3359057B1 (en) | 2015-10-07 | 2023-07-05 | Applied Medical Resources Corporation | Wound retractor with multi-segment outer ring |
CA3036192A1 (en) | 2016-09-12 | 2018-03-15 | Applied Medical Resources Corporation | Surgical robotic access system for irregularly shaped robotic actuators and associated robotic surgical instruments |
US10737085B2 (en) * | 2017-05-05 | 2020-08-11 | Greatbatch Ltd. | Medical device with hemostatic valve |
EP3672682B1 (en) | 2017-08-23 | 2024-04-03 | C. R. Bard, Inc. | Catheter assemblies and methods thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5520655A (en) * | 1994-07-15 | 1996-05-28 | Cordis Corporation | Catheter hemostasis valve |
US5807350A (en) * | 1995-11-03 | 1998-09-15 | Cordis Corporation | Kink resistant catheter sheath introducer |
WO1999006099A2 (en) * | 1997-07-30 | 1999-02-11 | Cook Incorporated | Medical fluid flow control valve |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000739A (en) | 1975-07-09 | 1977-01-04 | Cordis Corporation | Hemostasis cannula |
US4254773A (en) | 1978-11-24 | 1981-03-10 | Medex Inc. | Swivel coupling for a catheterization system |
US4430081A (en) | 1981-01-06 | 1984-02-07 | Cook, Inc. | Hemostasis sheath |
US4366817A (en) | 1981-05-26 | 1983-01-04 | Burron Medical Inc. | Winged IV catheter |
US4436519A (en) | 1981-05-28 | 1984-03-13 | Argon Medical Corp. | Removable hemostasis valve |
US4424833A (en) | 1981-10-02 | 1984-01-10 | C. R. Bard, Inc. | Self sealing gasket assembly |
US4929235A (en) | 1985-07-31 | 1990-05-29 | Universal Medical Instrument Corp. | Self-sealing percutaneous tube introducer |
US5251873B1 (en) | 1992-06-04 | 1995-05-02 | Vernay Laboratories | Medical coupling site. |
US4798594A (en) | 1987-09-21 | 1989-01-17 | Cordis Corporation | Medical instrument valve |
US4895565A (en) | 1987-09-21 | 1990-01-23 | Cordis Corporation | Medical instrument valve |
US5059186A (en) | 1988-03-07 | 1991-10-22 | Vitaphore Corporation | Percutaneous access device |
US5098393A (en) | 1988-05-31 | 1992-03-24 | Kurt Amplatz | Medical introducer and valve assembly |
US4874378A (en) | 1988-06-01 | 1989-10-17 | Cordis Corporation | Catheter sheath introducer |
US4944729A (en) | 1988-08-29 | 1990-07-31 | Shiley, Inc. | Femoral arterial cannula |
US4950257A (en) | 1988-09-15 | 1990-08-21 | Mallinckrodt, Inc. | Catheter introducer with flexible tip |
US5000745A (en) | 1988-11-18 | 1991-03-19 | Edward Weck Incorporated | Hemostatis valve |
US4946133A (en) | 1988-11-21 | 1990-08-07 | Schneider (U.S.A.) Inc., A Pfizer Co. | Hemostasis valve |
US5499975A (en) | 1989-01-31 | 1996-03-19 | Cook Incorporated | Smooth transitioned dilator-sheath assembly and method |
US5045065A (en) | 1989-03-20 | 1991-09-03 | Raulerson J Daniel | Catheter introduction syringe |
JPH03242153A (en) | 1990-02-13 | 1991-10-29 | Daig Corp | Cylindrical plug to seal induction steel wire |
US5137519A (en) | 1990-03-12 | 1992-08-11 | Cordis Corporation | Catheter retention collar and support |
US5114408A (en) | 1990-10-18 | 1992-05-19 | Daig Corporation | Universal hemostasis valve having improved sealing characteristics |
JPH04170966A (en) | 1990-11-01 | 1992-06-18 | Nippon Sherwood Kk | Valvular body for catheter introducer blood stop valve |
US5242410A (en) | 1991-04-15 | 1993-09-07 | University Of Florida | Wireless high flow intravascular sheath introducer and method |
US5092857A (en) | 1991-05-17 | 1992-03-03 | Fleischhacker John J | Hemostasis valve having support shoulders |
US5154701A (en) | 1991-06-26 | 1992-10-13 | Adam Spence Corporation | Hemostasis valve |
DE4127628C1 (en) | 1991-08-21 | 1992-07-23 | Vygon Gmbh & Co Kg, 5100 Aachen, De | |
US5188607A (en) | 1991-11-12 | 1993-02-23 | Thomas Wu | Valve catheter connector assembly |
US5300033A (en) | 1992-07-09 | 1994-04-05 | Unisurge, Inc. | Introducer assembly and valve construction for use therein |
US5267966A (en) | 1992-09-28 | 1993-12-07 | Cook Incorporated | Hemostasis cannula and method of making a valve for same |
US5234410A (en) | 1992-10-23 | 1993-08-10 | Vlv Associates | Catheter assembly |
US5330435A (en) | 1993-04-08 | 1994-07-19 | Vaillancourt Vincent L | Valve for a catheter assembly |
US5613956A (en) | 1993-05-07 | 1997-03-25 | C. R. Bard, Inc. | Catheter introducer |
US5549576A (en) | 1993-05-07 | 1996-08-27 | C. R. Bard, Inc. | Vascular introducer valve with proximal self-lubrication |
US5350363A (en) | 1993-06-14 | 1994-09-27 | Cordis Corporation | Enhanced sheath valve |
US5538505A (en) | 1993-06-14 | 1996-07-23 | Cordis Corporation | Hemostasis valve for catheter introducer having thickened central partition section |
US5944697A (en) | 1994-05-31 | 1999-08-31 | Universal Medical Instrument Corp. | Percutaneous catheter introducer |
US5599305A (en) | 1994-10-24 | 1997-02-04 | Cardiovascular Concepts, Inc. | Large-diameter introducer sheath having hemostasis valve and removable steering mechanism |
US5762630A (en) | 1996-12-23 | 1998-06-09 | Johnson & Johnson Medical, Inc. | Thermally softening stylet |
US5911710A (en) | 1997-05-02 | 1999-06-15 | Schneider/Namic | Medical insertion device with hemostatic valve |
NL1007997C2 (en) | 1998-01-09 | 1999-07-12 | Cordis Europ | Device for inserting an elongated medical device. |
-
1999
- 1999-09-10 US US09/393,865 patent/US6322541B2/en not_active Expired - Lifetime
-
2000
- 2000-07-28 WO PCT/US2000/020581 patent/WO2001017586A1/en active IP Right Grant
- 2000-07-28 DE DE2000616785 patent/DE60016785T2/en not_active Expired - Lifetime
- 2000-07-28 EP EP20000950838 patent/EP1225932B1/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5520655A (en) * | 1994-07-15 | 1996-05-28 | Cordis Corporation | Catheter hemostasis valve |
US5807350A (en) * | 1995-11-03 | 1998-09-15 | Cordis Corporation | Kink resistant catheter sheath introducer |
WO1999006099A2 (en) * | 1997-07-30 | 1999-02-11 | Cook Incorporated | Medical fluid flow control valve |
Non-Patent Citations (1)
Title |
---|
See also references of EP1225932A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003008035A1 (en) * | 2001-07-16 | 2003-01-30 | Boston Scientific Limited | Hemostasis gasket valve |
US6776774B2 (en) | 2001-07-16 | 2004-08-17 | Scimed Life Systems, Inc. | Hemostasis gasket valve |
Also Published As
Publication number | Publication date |
---|---|
EP1225932B1 (en) | 2004-12-15 |
DE60016785T2 (en) | 2005-12-15 |
EP1225932A1 (en) | 2002-07-31 |
DE60016785D1 (en) | 2005-01-20 |
US6322541B2 (en) | 2001-11-27 |
EP1225932A4 (en) | 2003-01-22 |
US20010001813A1 (en) | 2001-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6322541B2 (en) | Vascular introducer sheath and hemostasis valve for use therewith | |
EP1409069B1 (en) | Hemostasis gasket valve | |
US5006113A (en) | Hemostasis cannula | |
US7081106B1 (en) | Hemostasis valve | |
US6142981A (en) | Hemostasis valve | |
EP1250171B1 (en) | Hemostasis valve | |
US8753317B2 (en) | Hemostasis cannula | |
US5538505A (en) | Hemostasis valve for catheter introducer having thickened central partition section | |
JP2571353B2 (en) | Catheter tube | |
US5273546A (en) | Hemostasis valve | |
US5520655A (en) | Catheter hemostasis valve | |
EP0370721B1 (en) | Hemostasis valve | |
US20040127855A1 (en) | Hemostasis valve | |
WO1993002734A1 (en) | Hemostasis valve | |
JPH04170966A (en) | Valvular body for catheter introducer blood stop valve | |
AU650357B2 (en) | Hemostasis cannula | |
EP0868203B1 (en) | Hemostasis cannula | |
JP3486353B2 (en) | Medical valve | |
JPH02948B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000950838 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000950838 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000950838 Country of ref document: EP |